Perphenazine (Trilafon): How This Antipsychotic Works, Dosing, and When Telehealth Is Enough

Last updated: August 23, 2026

Perphenazine is a first-generation (typical) antipsychotic. Tablets come as 2 mg, 4 mg, 8 mg, and 16 mg. The historic brand Trilafon is discontinued. Generic tablets remain. Perphenazine is not a controlled substance. The FDA label lists two adult uses: schizophrenia, and control of severe nausea and vomiting.

This guide covers what perphenazine treats, how outpatient and hospital dosing usually starts, why CYP2D6 and movement side effects matter, and which parts of care a telehealth visit can handle. It is educational, not a diagnosis or a promise that any plan will pay for a specific medicine.

See if you may qualify for online mental health care →

What is perphenazine?

According to MedlinePlus (revised November 15, 2025), perphenazine treats symptoms of schizophrenia and also controls severe nausea and vomiting. It belongs to the antipsychotic class and reduces abnormal excitement in the brain. Tablets are taken two to four times a day. Brand name: Trilafon (discontinued).

The DailyMed perphenazine tablet label (updated November 1, 2024; Wilshire) describes a piperazinyl phenothiazine. Each film-coated tablet contains 2 mg, 4 mg, 8 mg, or 16 mg of perphenazine. DEA schedule: none.

LiverTox lists the historic brand as Trilafon and classifies perphenazine among antipsychotic agents. Combination products with amitriptyline (historic Duo-Vil, Etrafon, Triavil) appear on MedlinePlus; several of those brands are also discontinued.

What does perphenazine treat?

DailyMed indications:

• Treatment of schizophrenia.
• Control of severe nausea and vomiting in adults.

MedlinePlus notes the same two uses. If a clinician uses perphenazine for nausea, tell them about listlessness, confusion, seizures, vision or balance problems, or severe abdominal pain, because those symptoms can point to a different emergency.

Providers sometimes use perphenazine off-label for other psychiatric conditions. Off-label use needs a clear clinical reason and a discussion of alternatives.

How do you take perphenazine?

MedlinePlus: tablets by mouth, two to four times a day, at about the same times. The prescriber may start at an average dose and later lower it once symptoms are controlled. Perphenazine controls symptoms; it does not cure schizophrenia. Do not stop suddenly. Abrupt stop can cause nausea, vomiting, stomach pain, dizziness, and shakiness. Taper.

DailyMed dosing:

• Moderately disturbed nonhospitalized patients with schizophrenia: 4 to 8 mg three times daily at first; reduce as soon as possible to the lowest effective dose.
• Hospitalized patients with schizophrenia: 8 to 16 mg two to four times daily; avoid more than 64 mg daily.
• Severe nausea and vomiting in adults: 8 to 16 mg daily in divided doses; 24 mg is occasionally necessary; reduce early when you can.

DailyMed: prolonged use above 24 mg daily should stay reserved for hospitalized patients or people under continued observation so staff can catch adverse reactions early. An antiparkinson agent such as trihexyphenidyl or benztropine can help drug-induced extrapyramidal symptoms.

Missed dose (MedlinePlus): take it when you remember unless the next dose is near. Do not double up.

Browse conditions and next steps →

How does the body handle perphenazine?

DailyMed pharmacokinetics:

• Peak plasma levels about 1 to 3 hours after a tablet.
• Elimination half-life about 9 to 12 hours, independent of dose.
• In volunteers taking 4 mg every 8 hours, steady state arrived within 72 hours.
• The liver metabolizes it extensively, including through CYP2D6. About 7% to 10% of people of European ancestry, and a smaller share of people of Asian ancestry, are CYP2D6 poor metabolizers. They clear perphenazine more slowly and see higher levels.

A clinician may go slower, or stay lower, if genetic testing or prior drug reactions suggest poor CYP2D6 activity.

What side effects should you watch for?

Common effects from MedlinePlus include dizziness or unsteadiness, blurred vision, dry mouth or extra saliva, headache, nausea or constipation, restlessness, sleep trouble, urination changes, skin color change, breast enlargement or milk production, missed periods, and lower sexual function in men.

Serious effects that need urgent care:

• Neuroleptic malignant syndrome pattern: fever, stiff muscles, confusion, sweating, fast or irregular heartbeat.
• Tardive dyskinesia: worm-like tongue movements; rhythmic face, mouth, or jaw movements.
• Acute dystonia: neck cramps, tongue that sticks out, throat tightness, trouble swallowing or breathing.
• Seizures, falls, yellowing of skin or eyes, infection signs (sore throat, fever, chills), rash or swelling that suggests allergy.

DailyMed boxed warning: older adults with dementia-related psychosis have a higher death risk on antipsychotics. In 17 placebo-controlled trials (about 10 weeks), drug-treated patients had about 1.6 to 1.7 times the death risk of placebo. About 4.5% died versus 2.6% on placebo. Most deaths were cardiovascular or infectious. Perphenazine is not approved for dementia-related psychosis.

MedlinePlus: perphenazine can raise sun sensitivity and make it harder to cool down in heat. Home pregnancy tests can be unreliable. Do not rely on a home kit.

Who should not take perphenazine?

DailyMed contraindications:

• Coma or a greatly obtunded state; large doses of CNS depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines).
• Existing blood dyscrasias, bone marrow depression, or liver damage.
• Hypersensitivity to perphenazine, its components, or related compounds.
• Suspected or established subcortical brain damage (with or without hypothalamic damage), because a hyperthermic reaction above 104°F can appear, sometimes 14 to 16 hours after a dose.

MedlinePlus also flags extra caution for pheochromocytoma, breast cancer, seizures, abnormal EEG, depression, lung disease, heart or kidney disease, alcohol withdrawal, and prior severe reactions to psychiatric medicines.

Alcohol can worsen sedation. Do not drive until you know how you react. Stand up slowly.

Overdose (MedlinePlus): poor response to surroundings, coma, seizures, fast or irregular heartbeat. Poison Control: 1-800-222-1222.

When is telehealth enough?

HHS notes that telehealth remains widely used for behavioral health and can improve access and continuity. A licensed telehealth clinician can review history, discuss oral antipsychotic options, check side effects, and coordinate labs when needed.

Perphenazine is not a controlled substance, so federal scheduling is not the barrier. Schizophrenia care still needs a careful diagnosis, a plan for movement side effects, and a path to in-person or emergency care if NMS, severe dystonia, or acute psychosis appears. Doses above 24 mg daily, per the label, belong with closer observation than a typical video follow-up alone.

Klarity Health works with 2,000+ licensed providers. Many people use telehealth for depression, anxiety, and related medication follow-up. Coverage for visits and medicines varies by plan. Verify benefits before you book. If you already take an antipsychotic such as loxapine or fluphenazine (Prolixin), a clinician can compare classes rather than switch you without a reason.

Need immediate support? Call or text 988 (Suicide & Crisis Lifeline). If someone cannot stay safe, call 911.

Insurance and cost

Many commercial and Medicare plans may cover generic oral perphenazine. Prior authorization is common for antipsychotics. Coverage varies by plan. Confirm benefits, copays, and pharmacy network rules before you rely on a specific fill.

This article does not state that any insurer covers perphenazine. A Klarity visit is a clinical evaluation. A prescription is never guaranteed.

Frequently asked questions

Is perphenazine the same as Trilafon?

Trilafon was the brand name. MedlinePlus marks Trilafon as discontinued. Generic 2, 4, 8, and 16 mg tablets remain.

Is perphenazine a controlled substance?

No. DailyMed lists DEA schedule as none.

What is a typical outpatient dose for schizophrenia?

DailyMed: 4 to 8 mg three times daily at first for moderately disturbed people who are not in the hospital, then the lowest dose that holds symptoms. Stay under continued observation if the dose stays above 24 mg daily for a long period.

Can telehealth prescribe perphenazine for nausea?

A clinician can discuss severe nausea, but the label is for severe adult nausea and vomiting, and other red-flag symptoms need in-person evaluation. Do not treat unexplained vomiting as a simple refill request.

Why does CYP2D6 matter?

DailyMed: poor CYP2D6 metabolizers clear perphenazine more slowly and reach higher levels. That can change side-effect risk and how high a clinician is willing to go.

Bottom line

Perphenazine is a typical phenothiazine antipsychotic for schizophrenia and for severe adult nausea and vomiting. Tablets come as 2, 4, 8, and 16 mg. Outpatient schizophrenia starts often sit at 4 to 8 mg three times daily. Hospital regimens can go higher, not above 64 mg daily. Boxed warning: dementia-related psychosis. Telehealth can support evaluation and oral follow-up. It cannot replace emergency or inpatient care when NMS, severe EPS, or acute medical vomiting appears.

See if you may qualify →

Disclaimer: This article is for education only. It is not medical advice, a diagnosis, or a guarantee of insurance coverage. Coverage varies by plan. Verify benefits before booking. Talk with a licensed clinician about your own care. If you are in crisis, call or text 988 or call 911.